glp-1 weight loss journey 2024 in Review: The Rise of Medications for Month 1 of my GLP-1

For tirzepatide (Zepbound) Jastreboff and colleagues reported in the New England Journal of Medicine in 2022 that at maximal doses, the percent of individuals reporting side effects were as follows: Nausea 31.0% Diarrhea 23.0% Vomiting 12.2% Constipation 11.7% Bettge and colleagues conducted a study published in Diabetes, Obesity, and Metabolism in 2017 that showed that individuals who were taking metformin while taking a GLP-1 were more likely to have side effects, especially nausea and vomiting

doi: 10.1186/s12933-021-01366-8 88 LeeMMYKristensenSLGersteinHCMcMurrayJJVSattarN

Lifestyle interventions remain the cornerstone of long-term management for both type 2 diabetes and obesity

Calculate GLP-1 Weight Loss Projector Project realistic mean weight loss on semaglutide, tirzepatide, or liraglutide using STEP 1, SURMOUNT-1, and SCALE trial data